{"contentid": 488537, "importid": NaN, "name": "Positive top-line results for Sobi\u00e2\u0080\u0099s anakinra in COVID-19 pneumonia", "introduction": "Swedish Orphan Biovitrum and the Hellenic Institute for the Study of Sepsis have announced positive top-line results from the Investigator-sponsored SAVE-MORE study, which assessed the effect of anakinra in moderate-to-severe COVID-19 pneumonia.", "content": "<p>Swedish Orphan Biovitrum (STO: SOBI) and the Hellenic Institute for the Study of Sepsis have announced positive top-line results from the Investigator-sponsored SAVE-MORE study, which assessed the effect of anakinra in moderate-to-severe COVID-19 pneumonia.</p>\n<p>Early and targeted use of anakinra in addition to current standard of care in hospitalized patients with poor prognosis prevented either death or progression to severe respiratory failure, while increasing the number of patients who were discharged from hospital with no evidence of COVID-19 infection, the company said.</p>\n<p><span class=\"pullQuote\">\"It is clear that there is still a considerable unmet medical need for COVID-19 despite recent advances in treatment\"</span>SAVE-MORE is a large, randomized controlled trial in over 600 hospitalized patients that specifically identifies those at risk of severe respiratory failure by the measurement of elevated soluble urokinase plasminogen activator receptor, a plasma biomarker that reflects immune activation and has been previously associated with poor prognosis in a number of conditions.</p>\n<p>The study is sponsored by the Hellenic Institute for the Study of Sepsis in Greece and led by its president and chairman, Evangelos Giamarellos-Bourboulis, whose other roles also include president of the European Shock Society and chairman of the European Sepsis Alliance.</p>\n<p>He said: &ldquo;This is the first study to specifically evaluate an at-risk patient population before admission to intensive care unit. The results provide a significant step forward in the search for additional treatment options to prevent progression to a more critical state.&rdquo;</p>\n<p>Sobi intends to discuss the results with regulatory authorities to evaluate the possibility of approval.</p>\n<p>Ravi Rao, head of research and development and chief medical officer at Sobi, added: &ldquo;It is clear that there is still a considerable unmet medical need for COVID-19 despite recent advances in treatment.</p>\n<p>&ldquo;These important data come at a critical time and we plan to continue our ongoing dialogue with the European Medicines Agency in collaboration with Professor Giamarellos-Bourboulis.&rdquo;</p>", "date": "2021-05-04 17:47:00", "meta_title": NaN, "meta_keywords": NaN, "meta_description": NaN, "meta_robots": NaN, "meta_display_in_sitemap": 1, "canonical_url": NaN, "status": 1, "access_status": 0, "ignore_flexible_sampling": 0, "display_start_date": "0000-00-00 00:00:00", "display_end_date": "0000-00-00 00:00:00", "display_in_search": 1, "created": "2021-05-04 17:31:10", "updated": "2021-05-04 22:43:56", "access": NaN, "url": "https://www.thepharmaletter.com/article/positive-top-line-results-for-sobi-s-anakinra-in-covid-19-pneumonia", "description": NaN, "twitter_term": NaN, "twitter_widgetid": NaN, "key_facts": NaN, "news_snippet": NaN, "image1id": "sobi_large.jpg", "image2id": "sobi_small.jpg", "restrict_print": 0, "restrict_print_for_logged_out": 0, "box1_header": NaN, "box1_title": NaN, "box1_image1id": 0, "box1_url": NaN, "box1_introduction": NaN, "box1_position": 0, "tags": NaN, "sector_tag": "Biotechnology", "therapy area_tag": "Infectious diseases, Respiratory and Pulmonary", "topic_tag": "Coronavirus, Drug Trial, Focus On, Research", "geography_tag": "Sweden", "company_tag": "Swedish Orphan Biovitrum", "drug_tag": "Anakinra", "market index_tag": NaN, "theme_tag": NaN, "industry sector_tag": NaN, "medical condition_tag": NaN, "industry term_tag": NaN, "organization_tag": NaN, "person_tag": NaN, "position_tag": NaN, "medical treatment_tag": NaN, "facility_tag": NaN, "technology_tag": NaN, "journalist_tag": NaN, "published medium_tag": NaN, "political event_tag": NaN, "anniversary_tag": NaN, "sports event_tag": NaN, "movie_tag": NaN, "fax number_tag": NaN, "currency pair_tag": NaN, "sports league_tag": NaN, "date_tag": NaN, "music group_tag": NaN, "phone number_tag": NaN, "t v show_tag": NaN, "t v station_tag": NaN, "entertainment award event_tag": NaN, "industry_tag": NaN, "pharmaceutical drug_tag": NaN, "topmost public parent company_tag": NaN, "content_type_name": "Article", "pubDate": "2021-05-04 17:47:00"}